$RR

RICHTECH ROBOTICS INC.

CIK:0001963685|SEC Filings

Unaudited Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenues, net	$ 1,373	$ 1,177	$ 3,945	$ 3,601
Cost of revenues	571	746	2,448	1,991
Gross profit	802	431	1,497	1,610
Operating expenses:
Research and development	950	533	3,144	1,337
Sales and marketing	602	288	4,011	903
General and administrative	3,049	1,409	15,546	10,180
Impairment of long-lived assets	9,468		9,468
Total operating expenses	14,069	2,230	32,169	12,420
Loss from operations	(13,267)	(1,799)	(30,672)	(10,810)
Non-operating income(expense):
Investment Income	3,111	423	9,848	1,143
Gain (loss) from change in fair value of warrant liability	177	(286)	552	(22,123)
Loss on disposition of subsidiary			(132)
Interest expense, net	(2)	(19)	(6)	(28)
Total other income (expense)	3,286	118	10,262	(21,008)
Loss before income tax expense	(9,981)	(1,681)	(20,410)	(31,818)
Income tax benefit/(expense)		(9)		(9)
Net loss	(9,981)	(1,690)	(20,410)	(31,827)
Less: Net loss Attributable to Non-Controlling Interest		(40)	(8)	(78)
Net loss attributable to Richtech	$ (9,981)	$ (1,650)	$ (20,402)	$ (31,749)
Basic net loss per share of Richtech (in Dollars per share)	$ (0.04)	$ (0.01)	$ (0.09)	$ (0.29)
Diluted net loss per share of Richtech (in Dollars per share)	$ (0.04)	$ (0.01)	$ (0.09)	$ (0.29)
Weighted average shares used to compute basic net loss per share (in Shares)	224,320,751	119,585,747	217,342,358	110,225,078
Weighted average shares used to compute diluted net loss per share (in Shares)	224,320,751	119,585,747	217,342,358	110,225,078

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating Activities:
Net loss	$ (20,410)	$ (31,827)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	1,228	941
Impairment of long-lived assets	9,468
Allowance for credit loss	886	(111)
Allowance for inventory obsolescence and slow-moving inventory	41
Loss on disposition of subsidiary	132
Change in fair value of warrant liability	(552)	22,123
Liability instrument issuance costs		189
Stock based compensation	9,006	3,429
Change in operating assets and liabilities:
Accounts receivable	(28)	(224)
Inventory	(1,118)	(3)
Prepaid expenses and other current assets	(1,126)	(133)
Right-of-use asset	116	(289)
Other noncurrent assets	(13)
Accounts payable	(43)	187
Deferred revenue	140
Tax payable	24	35
Accrued expenses and other payables	(1,219)	(15)
Operating lease liabilities	(100)	289
Net cash used in operating activities	(3,568)	(5,409)
Cash flows from investing activities:
Purchase of property and equipment	(21,749)	(4,839)
Purchase of intangible assets	(30)	(84)
Purchase of short-term investments	(68,273)	(36,676)
Net cash effect of deconsolidation of subsidiary	(3)
Proceeds from sale of long-term investments	193
Purchase of long-term investments	(18)	(142)
Proceeds from maturities and sales of short-term investments	96,848
Net cash provided by (used in) investing activities	6,968	(41,741)
Cash flows from financing activities:
Payment of loans received from third parties	(16)	(53)
Loans received from third parties		22
Payments of tax withholdings for restricted stock awards	(1,769)
Contributions from Non-controlling Interests	4
Proceeds from warrants exercise	9,812	18,038
Payment of issuance cost of ordinary shares	(5,344)	(1,180)
Proceeds from issuance of ordinary shares	110,301	48,650
Net cash provided by financing activities	112,988	65,477
Net change in cash and cash equivalents	116,388	18,327
Cash and cash equivalents at beginning of the period	185,574	14,566
Cash and cash equivalents at end of the period	301,962	32,893
Supplemental noncash disclosures:
Intangible assets acquired in exchange for common shares		3,701
Reduction of ROU asset from partial termination	97
Reduction of lease liability from partial termination	104
Transfer of notes receivable in settlement for inventory purchases	523
Reclassification of warrant from mezzanine equity to permanent equity upon exercise	$ 385

Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Sep. 30, 2025
Current assets:
Cash and cash equivalents	$ 301,962	$ 185,574
Short-term investments	37,633	66,363
Accounts receivable, net	922	1,780
Inventory	2,715	1,124
Prepaid expenses and other current assets	1,552	429
Total current assets	344,784	255,270
Property and equipment, net	27,181	5,794
Notes receivable		523
Operating lease right-of-use assets	615	731
Intangible assets, net	371	10,715
Other assets, non-current	443	640
Total assets	373,394	273,673
Current liabilities:
Accounts payable	348	397
Deferred revenue	388	248
Accrued expenses and other payables	157	1,376
Tax payables	79	55
Operating lease liabilities, current	310	301
Warrant liabilities	2,401	19,285
Total current liabilities	3,683	21,662
Long-term payables	102	118
Operating lease liabilities, non-current	319	429
Total liabilities	4,104	22,209
Commitments and contingencies (Notes 11)
Mezzanine equity	249	634
Stockholders’ equity:
Additional Paid-in Capital	441,191	300,701
Accumulated other comprehensive income	239	393
Accumulated deficit	(70,643)	(50,241)
Treasury stock, at cost; 396,724 and nil shares, as of June 30, 2026 and September 30, 2025, respectively	(1,769)
Total controlling stockholders’ equity	369,041	250,873
Non-controlling interests		(43)
Total stockholders’ equity	369,041	250,830
Total liabilities, mezzanine equity and stockholders’ equity	373,394	273,673
Class A Common Stock
Stockholders’ equity:
Common stock, value	4	4
Class B Common Stock
Stockholders’ equity:
Common stock, value	$ 19	$ 16